Inventor · disambiguated record
Qingyi Li
Also filed as: LI QINGYI
16 granted patents·11 pending applications·17 citations·filing 2009–2024
88Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS VI LLC7FULCRUM THERAPEUTICS INC4DICERNA PHARMACEUTICALS INC2GU SHUHUA2CHANGZHOU HI TECH DISTR MULTIPLE DIMENSION INDU1
Top patents by PatentIndex Score
27 records- 0194US10973805B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 13, 2021·5 cites·20 claims
- 0291US11590111B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·10 claims
- 0386US11414659B24'-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2017·Granted Aug 16, 2022·3 cites·44 claims
- 0483US2025195480A1Macrocyclic azolopyridine derivatives as eed and prc2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0581US12109198B2Macrocyclic azolopyridine derivatives as EED and PRC2 modulatorsFULCRUM THERAPEUTICS INC·Filed 2022·Granted Oct 8, 2024·0 cites·5 claims
- 0678US12161970B1CO2 desorption system suitable for limited space in complex sailing region and flexible control methodJIAXING RESEARCH INSTITUTE ZHEJIANG UNIV·Filed 2024·Granted Dec 10, 2024·1 cites·8 claims
- 0771US9096493B2Preparation method of high-purity L-carnitineGU SHUHUA·Filed 2009·Granted Aug 4, 2015·1 cites·16 claims
- 0870US12037586B24′-phosphate analogs and oligonucleotides comprising the sameDICERNA PHARMACEUTICALS INC·Filed 2022·Granted Jul 16, 2024·0 cites·26 claims
- 0969US10428072B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Oct 1, 2019·1 cites·58 claims
- 1069US2025000890A1Trem compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2024·Application pending·0 cites
- 1164USD1044324SStorage rackCHANGZHOU WORMHOLE HOME INTELLIGENT TECH CO LTD·Filed 2023·Granted Oct 1, 2024·3 cites·1 claims
- 1263US12121531B2TREM compositions and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Oct 22, 2024·0 cites·10 claims
- 1359US2025179492A1Compositions of modified trems and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 1458US2024401047A1Trem compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Application pending·0 cites
- 1555US9394308B2Inhibiting the transient receptor potential A1 ion channelMERCK SHARP & DOHME·Filed 2014·Granted Jul 19, 2016·0 cites·8 claims
- 1655US2023203509A1Trem compositions and methods relating theretoFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 1753US9421181B2Antihypoxic pharmaceutical composition and application thereofCHANGZHOU HI-TECH DISTR MULTIPLE DIMENSION IND TECH INST CO LTD·Filed 2014·Granted Aug 23, 2016·1 cites·22 claims
- 1851US11980844B2Method for carbon dioxide capture and concentration by partitioned multistage circulation based on mass transfer-reaction regulationUNIV ZHEJIANG·Filed 2021·Granted May 14, 2024·0 cites·8 claims
- 1951US2023203510A1Trem compositions and methods relating theretoFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 2050US11472775B2Halogen-substituted compound, preparation method therefor, and use thereofSUQIAN KEYLAB BIOCHEMICAL CO LTD·Filed 2019·Granted Oct 18, 2022·0 cites·8 claims
- 2150US2024175020A1Compositions of modified trems and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Application pending·0 cites
- 2250US2014158116A1Inhibiting trpa1 for the treatment of asthmaCUBIST PHARM INC·Filed 2013·Application pending·0 cites
- 2340US8709819B2Preparation and its use of derivatization reagent for detecting L-carnitine or D-carnitineGU SHUHUA·Filed 2009·Granted Apr 29, 2014·0 cites·14 claims
- 2439US10457645B2Method for the preparation of 3-fluoroalkyl-1-methylpyrazol-4-carboxylic acidSOLVAY FLUOR GMBH·Filed 2016·Granted Oct 29, 2019·0 cites·13 claims
- 2538US2016106741A1Oral pharmaceutical composition for increasing hypoxia toleranceCHANGZHOU HI TECH DISTR MULTIPLE DIMENSION INDUSTRY TECHNOLOGY INST CO LTD·Filed 2014·Application pending·0 cites
- 2636US2017050966A1Inhibiting the transient receptor potential a1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
- 2735US2018117036A1Oral pharmaceutical composition for increasing hypoxia toleranceCHANGZHOU HI TECH DISTR MULTIPLE DIMENSION INDU·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qingyi Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →